30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2014 Revenue: LDR

4Q14 revenue: $39.5MM, +24% (U.S. $32MM, +29%; ex-U.S. $7.5MM, +6%)

  • Traditional Fusion $3.7MM, -19%
  • Exclusive Technologies $35.8MM, +31% (Cervical $25.5MM, +47%; Lumbar $10.3MM, +2%)

 

Cervical led by Mobi-C, ROI-C

In U.S., achieved record number of Mobi-C and ROI-C cases performed and number of surgeon users

VerteBRIDGE fusion products benefiting from cross-sales to surgeons trained on Mobi-C

Presented key 5-year data on 1- and 2-level Mobi-C vs. traditional fusion

 

2014 revenue: $141.3MM, +27% (U.S. $109.6MM, +33%; ex-U.S. $31.7MM, +8%)

  • Traditional Fusion $16.2MM, -15%
  • Exclusive Technologies $125.0MM, +35% (Cervical +48%, Lumbar +13%)

 

To date, >80,000 VerteBRIDGE and >30,000 Mobi-C implantations worldwide; trained ~1,000 U.S. surgeons on latter in 2014 (~1,500-1,600 worldwide, overall)

Received specific U.S. Category I CPT reimbursement code for 2-level cervical discs in 1Q15

Planning 3 new product launches over 2015 in Exclusive Lumbar, including 2Q15 U.S. limited launch of InterBRIDGE Interspinous fusion system (preserving supraspinous ligament; full launch to come in 2016)